In an analysis of 937 CCA patients, KRAS mutations were detected in 15.6% cases, with the most frequent allelic variants being G12D (37.0%), G12V (24.0%), and Q61H (8.2%) [19]. This evidence concerns the gene KRAS and cholangiocarcinoma.